Actavis Totowa LLC announced the voluntary recall of Digitek® (digoxin) for all tablets under both the “Bertek” and “UDL” label…Learn more >

Erythropoetin Stimulating Agents and Chemotherapy Induced Anemia - Emerging Safety Concerns. Erythropoetin Stimulating Agents (ESA’s) are approved to treat anemia in cancer patients…Learn more >

FDA Alert – New Avandia® Warning Information Reflects Possible Heart Attack Risk. The FDA informed healthcare professionals of new information about potential increased risk for heart attacks added to the existing boxed warning in Avandia's prescribing information… Learn more >

A Generics First Antidepressant Program will be starting soon, beginning in Idaho. The antidepressant market has substantially changed over the last several years and more are available generically and for the majority of patients, generic SSRIs provide effective treatment. Learn more>